Tim Czartoski, an orthopaedic executive who previously led DePuy Synthes U.S. as president and most recently headed U.S. Surgical and Global R&D at Enovis, has joined the board of directors at Peptilogics.
His experience running large orthopaedic device businesses, including launches of robotic technology platforms and one of the sector's most advanced knee systems, should count as Peptilogics works to bring its own innovation to market.
Czartoski spent 22 years at DePuy Synthes, part of Johnson & Johnson, where he led the USD 5.4 billion US orthopaedics business spanning joint reconstruction, trauma, spine, sports medicine and craniomaxillofacial. He then moved to Enovis as president of U.S. Surgical and Global R&D.
He also volunteers as a board director at Matthew 25, a local clinic providing free healthcare to people without insurance. He holds an M.S. in technology management from Columbia University, an MBA from the University of Notre Dame and a B.S. from The Ohio State University.
